Mon, November 8, 2010
Sun, November 7, 2010
Sat, November 6, 2010
Fri, November 5, 2010
Thu, November 4, 2010
Wed, November 3, 2010
Tue, November 2, 2010
Mon, November 1, 2010
Sat, October 30, 2010
Fri, October 29, 2010
Thu, October 28, 2010
Wed, October 27, 2010
Tue, October 26, 2010
Mon, October 25, 2010
Sun, October 24, 2010
[ Sun, Oct 24th 2010 ] - Market Wire
Alcon Board Elects New Chairman
Sat, October 23, 2010
Fri, October 22, 2010
Thu, October 21, 2010
Wed, October 20, 2010

Celgene Corporation to Present at Oppenheimera?s 21st Annual Healthcare Conference


//health-fitness.news-articles.net/content/2010/ .. heimera-s-21st-annual-healthcare-conference.html
Published in Health and Fitness on Friday, October 29th 2010 at 4:43 GMT by Market Wire   Print publication without navigation


SUMMIT, N.J.--([ BUSINESS WIRE ])--Celgene Corporation (NASDAQ: CELG) today announced its presentation at Oppenheimera™s 21st Annual Healthcare Conference on Tuesday, November 2, 2010 at 11:25 a.m. ET will be webcast live and will be available in the investor relations section of the companya™s Web site at [ www.celgene.com ]. Celgene management will provide an overview of the company.

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the companya™s Web site at [ www.celgene.com ].

This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the companya™s control. The companya™s actual results, performance, or achievements could be materially different from those projected by these forward-looking statements.The factors that could cause actual results, performance, or achievements to differ from the forward-looking statements are discussed in the companya™s filings with the Securities and Exchange Commission, such as the companya™s Form 10-K, 10-Q and 8-K reports. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements.


Publication Contributing Sources